Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
3.
Rheum Dis Clin North Am ; 37(2): 173-83, v, 2011 May.
Article in English | MEDLINE | ID: mdl-21444018

ABSTRACT

Inclusion body myositis (IBM) is the most common acquired myopathy in people older than 50 years. IBM typically presents with distal upper extremity weakness accompanied by proximal lower extremity muscle weakness. Associated clinical findings include asymmetric weakness, foot drop, and dysphagia. The pathogenesis of IBM is not clear. In this article the authors briefly discuss postulated pathogenic mechanisms. Although no proven pharmacotherapy exists, some promising candidates are discussed.


Subject(s)
Myositis, Inclusion Body , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antibodies, Monoclonal/therapeutic use , Diagnosis, Differential , Etanercept , Humans , Immunoglobulin G/therapeutic use , Muscle, Skeletal/pathology , Muscle, Skeletal/physiopathology , Myositis, Inclusion Body/diagnosis , Myositis, Inclusion Body/drug therapy , Myositis, Inclusion Body/etiology , Polymyositis/diagnosis , Randomized Controlled Trials as Topic , Receptors, Tumor Necrosis Factor/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...